fanasil, pyrimethamine drug combination and amphotericin b

fanasil, pyrimethamine drug combination has been researched along with amphotericin b in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Brilhante, RS; de Aguiar Cordeiro, R; de Farias Marques, FJ; de Jesus Pinheiro Gomes Bandeira, T; de Oliveira Miranda, DF; Mourão, CI; Neto, LV; Rocha, MF; Sidrim, JJ; Teixeira, CE	1

Other Studies

1 other study(ies) available for fanasil, pyrimethamine drug combination and amphotericin b

Article	Year
Antifolates inhibit Cryptococcus biofilms and enhance susceptibility of planktonic cells to amphotericin B. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2013, Volume: 32, Issue:4 Topics: Amphotericin B; Antifungal Agents; Biofilms; Cryptococcosis; Cryptococcus gattii; Cryptococcus neoformans; Drug Combinations; Environmental Microbiology; Folic Acid Antagonists; Humans; Microbial Sensitivity Tests; Pyrimethamine; Sulfadoxine; Trimethoprim, Sulfamethoxazole Drug Combination	2013

Article

Year

Antifolates inhibit Cryptococcus biofilms and enhance susceptibility of planktonic cells to amphotericin B.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2013, Volume: 32, Issue:4

Topics: Amphotericin B; Antifungal Agents; Biofilms; Cryptococcosis; Cryptococcus gattii; Cryptococcus neoformans; Drug Combinations; Environmental Microbiology; Folic Acid Antagonists; Humans; Microbial Sensitivity Tests; Pyrimethamine; Sulfadoxine; Trimethoprim, Sulfamethoxazole Drug Combination

2013